Pages that link to "Q45258277"

The following pages link to A phase I and pharmacokinetic study of short infusions of UCN-01 in patients with refractory solid tumors (Q45258277):

Displaying 20 items.

• CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycle (Q24622357) (← links)
• Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy (Q26745686) (← links)
• The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity (Q28569166) (← links)
• A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies (Q30431388) (← links)
• Histone deacetylase inhibitors downregulate checkpoint kinase 1 expression to induce cell death in non-small cell lung cancer cells (Q33778532) (← links)
• A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas (Q33786955) (← links)
• Poly(ADP-ribose) polymerase 1 modulates the lethality of CHK1 inhibitors in carcinoma cells (Q34309934) (← links)
• Simultaneous exposure of transformed cells to SRC family inhibitors and CHK1 inhibitors causes cell death (Q35592015) (← links)
• A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial (Q35751850) (← links)
• Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation (Q35828643) (← links)
• Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial (Q35849547) (← links)
• GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. (Q36512934) (← links)
• Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors (Q36569099) (← links)
• New combination therapies with cell-cycle agents (Q36737314) (← links)
• Suppression of antifolate resistance by targeting the myosin Va trafficking pathway in melanoma. (Q36945947) (← links)
• Protein kinase C: an attractive target for cancer therapy. (Q41971372) (← links)
• ATR/CHK1 inhibitors and cancer therapy (Q47622968) (← links)
• Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia. (Q53234212) (← links)
• Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine (Q88595397) (← links)
• Review of Chromatographic Bioanalytical Assays for the Quantitative Determination of Marine-Derived Drugs for Cancer Treatment (Q90446915) (← links)